|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 750.57 USD | +0.61% |
|
+0.23% | -2.76% |
| Capitalization | 7.7TCr 6.52TCr 6TCr 5.68TCr 11TCr 7,12700Cr 11TCr 70TCr 28TCr 3,45500Cr 29TCr 28TCr 12,17700Cr | P/E ratio 2026 * |
19.3x | P/E ratio 2027 * | 15.8x |
|---|---|---|---|---|---|
| Enterprise value | 6.9TCr 5.84TCr 5.37TCr 5.09TCr 9.43TCr 6,38000Cr 9.59TCr 63TCr 25TCr 3,09300Cr 26TCr 25TCr 10,90000Cr | EV / Sales 2026 * |
4.38x | EV / Sales 2027 * | 3.81x |
| Free-Float |
77.36% | Yield 2026 * |
0.51% | Yield 2027 * | 0.58% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +0.61% | ||
| 1 week | +0.23% | ||
| Current month | -2.86% | ||
| 1 month | +1.78% | ||
| 3 months | +2.39% | ||
| 6 months | +29.85% | ||
| Current year | -2.76% |
| 1 week | 739.12 |  | 760.58 |
| 1 month | 727.96 | | 781.21 |
| Current year | 718.38 | | 821.11 |
| 1 year | 476.49 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +2.03% | 1.9% | 26 M€ | |
| -.--% | 1.85% | 2 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.61% | +0.23% | +33.28% | -7.21% | 7.7TCr | |
| +2.01% | -4.04% | +93.62% | +206.22% | 5.93TCr | |
| -0.93% | +60.10% | +60.10% | +60.10% | 5.07TCr | |
| +0.36% | +0.24% | -41.82% | -54.11% | 4.73TCr | |
| +0.76% | +2.53% | +49.52% | -39.32% | 2.6TCr | |
| -1.76% | +5.42% | +117.36% | -62.39% | 2.13TCr | |
| +2.62% | +1.82% | +68.05% | +32.53% | 1.95TCr | |
| +1.84% | +3.64% | +60.08% | +56.74% | 1.59TCr | |
| -0.98% | +2.90% | +126.60% | +360.13% | 1.49TCr | |
| -0.95% | +1.24% | -6.87% | +659.34% | 1.34TCr | |
| Average | +0.36% | +1.78% | +55.99% | +121.20% | 3.45TCr | |
| Weighted average by Cap. | +0.50% | +0.70% | +49.37% | +73.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.57TCr 1.33TCr 1.23TCr 1.16TCr 2.15TCr 1,45500Cr 2.19TCr 14TCr 5.63TCr 71TCr 5.9TCr 5.78TCr 2,48600Cr | 1.73TCr 1.47TCr 1.35TCr 1.28TCr 2.37TCr 1,60500Cr 2.41TCr 16TCr 6.21TCr 78TCr 6.51TCr 6.37TCr 2,74300Cr |
| Net income | 423.46Cr 358.71Cr 330.05Cr 312.37Cr 578.92Cr 39TCr 589.09Cr 3.87TCr 1.52TCr 19TCr 1.59TCr 1.56TCr 67TCr | 527.69Cr 447.01Cr 411.29Cr 389.26Cr 721.41Cr 49TCr 734.09Cr 4.82TCr 1.89TCr 24TCr 1.98TCr 1.94TCr 83TCr |
| Net Debt | -807.24Cr -683.81Cr -629.18Cr -595.47Cr -1.1TCr -75TCr -1.12TCr -7.37TCr -2.89TCr -36TCr -3.03TCr -2.97TCr -1,27600Cr | -1.09TCr -924.85Cr -850.96Cr -805.36Cr -1.49TCr -1,01000Cr -1.52TCr -9.97TCr -3.91TCr -49TCr -4.1TCr -4.01TCr -1,72600Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | 750.57 $ | +0.61% | 5,12,998 |
| 16/26/16 | 746.00 $ | -1.05% | 5,05,374 |
| 15/26/15 | 753.93 $ | -0.21% | 5,71,311 |
| 14/26/14 | 755.51 $ | +1.21% | 6,37,779 |
| 13/26/13 | 746.46 $ | -0.32% | 7,47,093 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition